$0 Annual R&D Allocation ↑ 18% YoY
0 Active Projects ↑ 23 New Q3
0 Patents Filed / Year ↑ 34% YoY
0 Researchers & Engineers ↑ 12% Headcount
Filter by Phase:
Aerospace & Defense Project ORBITAL-9 Hypersonic
Phase III

Thermal protection systems and scramjet propulsion optimization for Mach 12+ orbital insertion vehicles.

📅 Q2 2027 Target 💰 $1.2B Budget
Health Sciences GeneThread CRISPR-Next
Phase IV

Third-generation base editors with 99.98% specificity targeting hereditary cardiovascular disorders.

📅 Q4 2026 Target 💰 $840M Budget
Digital Systems NeuralMesh QPU Cluster
Phase V

Commercial quantum processing unit deployment for financial modeling and cryptographic infrastructure.

📅 Q1 2026 Target 💰 $2.1B Budget
Energy & Power Helios Grid Fusion Reactor
Phase II

Compact tokamak stabilization using AI-driven magnetic confinement and high-temperature superconductors.

📅 Q3 2028 Target 💰 $3.4B Budget
Robotics & Autonomous Project SYNAPSE Swarm
Phase I

Decentralized drone swarm intelligence for disaster response and precision agricultural monitoring.

📅 Q1 2029 Target 💰 $420M Budget
Advanced Materials CarbonWeave Structural Polymer
Phase III

Self-healing composite materials for aerospace fuselages and underwater infrastructure reinforcement.

📅 Q2 2027 Target 💰 $680M Budget

Cross-Pollination Innovation Model

Aevum Zenth doesn't research in silos. Our pipeline leverages shared computational resources, unified material science databases, and cross-divisional talent pools to accelerate commercialization timelines by an average of 40%.

67%
Shared Tech Transfer Rate
3.2 yrs
Avg. Lab-to-Market Time
$14.2B
Cumulative IP Valuation
41
University Partners
Phase I
24
Phase II
31
Phase III
29
Phase IV
36
Phase V
22